VNRX: Short Sellers Retreated — Now the Numbers Face a Real Test
VolitionRx walks into today's Q1 2026 print with a dramatically altered short-seller landscape — one where a massive cover-down has reshaped the positioning story entirely. The most striking shift is in short interest.…
